BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Righi E, Londero A, Carnelutti A, Baccarani U, Bassetti M. Impact of new treatment options for hepatitis C virus infection in liver transplantation. World J Gastroenterol 2015; 21(38): 10760-10775 [PMID: 26478668 DOI: 10.3748/wjg.v21.i38.10760]
URL: https://www.wjgnet.com/1007-9327/full/v21/i38/10760.htm
Number Citing Articles
1
Francesca Romana Ponziani, Francesca Mangiola, Cecilia Binda, Maria Assunta Zocco, Massimo Siciliano, Antonio Grieco, Gian Lodovico Rapaccini, Maurizio Pompili, Antonio Gasbarrini. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis CWorld Journal of Hepatology 2017; 9(7): 352-367 doi: 10.4254/wjh.v9.i7.352
2
Sachin Kumar, Salil V. Deo, Salah E. Altarabsheh, Shannon M. Dunlay, Nagaraju Sarabu, Basar Sareyyupoglu, Yakov Elgudin, Benjamin Medalion, Chantal ElAmm, Mahazarin Ginwalla, Michael Zacharias, Rodolpho Benatti, Guilherme H. Oliveira, Ahmet Kilic, Gregg C. Fonarow, Soon J. Park. Effect of Hepatitis C Positivity on Survival in Adult Patients Undergoing Heart Transplantation (from the United Network for Organ Sharing Database)The American Journal of Cardiology 2016; 118(1): 132 doi: 10.1016/j.amjcard.2016.04.023
3
Y. Li, S. Li, X. Duan, C. Yang, M. Xu, L. Chen. Hepatitis C: from discovery to cureISBT Science Series 2018; 13(3): 244 doi: 10.1111/voxs.12417
4
Nicholas A. Meanwell. 2015 Philip S. Portoghese Medicinal Chemistry Lectureship. Curing Hepatitis C Virus Infection with Direct-Acting Antiviral Agents: The Arc of a Medicinal Chemistry TriumphJournal of Medicinal Chemistry 2016; 59(16): 7311 doi: 10.1021/acs.jmedchem.6b00915
5
Esteban Sáez‐González, Carmen Vinaixa, Fernando San Juan, Vanesa Hontangas, Salvador Benlloch, Victoria Aguilera, Angel Rubín, María García, Martín Prieto, Rafa López‐Andujar, Marina Berenguer. Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT)Liver International 2018; 38(6): 1022 doi: 10.1111/liv.13618
6
T.C. Wirth, M.P. Manns. The impact of the revolution in hepatitis C treatment on hepatocellular carcinomaAnnals of Oncology 2016; 27(8): 1467 doi: 10.1093/annonc/mdw219
7
José María Moreno-Planas, Juan Ramón Larrubia-Marfil, Juan José Sánchez-Ruano, Julia Morillas-Ariño, Roberto Patón-Arenas, Rosa María Sáiz-Chumillas, Emilia Tébar-Romero, Alfredo Lucendo-Villarín, Pilar Gancedo-Bringas, Mario Solera-Muñoz, María del Mar Vicente-Gutiérrez, Elisa Martínez-Alfaro. Influencia de la puntuación MELD basal en la eficacia del tratamiento de la hepatitis C con sofosbuvir y simeprevirEnfermedades Infecciosas y Microbiología Clínica 2018; 36(5): 277 doi: 10.1016/j.eimc.2017.05.001
8
José María Moreno-Planas, Juan Ramón Larrubia-Marfil, Juan José Sánchez-Ruano, Julia Morillas-Ariño, Roberto Patón-Arenas, Rosa María Sáiz-Chumillas, Emilia Tébar-Romero, Alfredo Lucendo-Villarín, Pilar Gancedo-Bringas, Mario Solera-Muñoz, María del Mar Vicente-Gutiérrez, Elisa Martínez-Alfaro. Influence of baseline MELD score in the efficacy of treatment of hepatitis C with simeprevir and sofosbuvirEnfermedades infecciosas y microbiologia clinica (English ed.) 2018; 36(5): 277 doi: 10.1016/j.eimce.2018.03.002
9
Kristopher P. Croome, Amit K. Mathur, Surakit Pungpapong, David D. Lee, Adyr A. Moss, Charles B. Rosen, Julie K. Heimbach, C. Burcin Taner. Equivalent Outcomes With Retransplantation and Primary Liver Transplantation in the Direct-acting Antiviral EraTransplantation 2019; 103(6): 1168 doi: 10.1097/TP.0000000000002460
10
Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz, Christian Gluud. Direct-acting antivirals for chronic hepatitis CCochrane Database of Systematic Reviews 2017;  doi: 10.1002/14651858.CD012143.pub2
11
Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kiran Kumar Katakam, Kristina Fobian, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz, Christian Gluud. Direct-acting antivirals for chronic hepatitis CCochrane Database of Systematic Reviews 2017; 2017(9) doi: 10.1002/14651858.CD012143.pub3
12
Sean M. McConachie, Sheila M. Wilhelm, Pramodini B. Kale-Pradhan. New direct-acting antivirals in hepatitis C therapy: a review of sofosbuvir, ledipasvir, daclatasvir, simeprevir, paritaprevir, ombitasvir and dasabuvirExpert Review of Clinical Pharmacology 2016; 9(2): 287 doi: 10.1586/17512433.2016.1129272
13
Alice Tung Wan Song, Rodolphe Sobesky, Carmen Vinaixa, Jérôme Dumortier, Sylvie Radenne, François Durand, Yvon Calmus, Géraldine Rousseau, Marianne Latournerie, Cyrille Feray, Valérie Delvart, Bruno Roche, Stéphanie Haim-Boukobza, Anne-Marie Roque-Afonso, Denis Castaing, Edson Abdala, Luiz Augusto Carneiro D’Albuquerque, Jean-Charles Duclos-Vallée, Marina Berenguer, Didier Samuel. Predictive factors for survival and score application in liver retransplantation for hepatitis C recurrenceWorld Journal of Gastroenterology 2016; 22(18): 4547-4558 doi: 10.3748/wjg.v22.i18.4547
14
M. Alfageme Zubillaga, T. Fontanilla Echeveste, I. Pérez González, A. Royuela Vicente, A.M. Duca, R.M. Ruiz Peralbo, C. González Hernando. Elastografía tipo ARFI: modificación tras tratamiento antiviral en el trasplante hepático con recidiva por VHCRadiología 2017; 59(2): 139 doi: 10.1016/j.rx.2016.12.004
15
M. Alfageme Zubillaga, T. Fontanilla Echeveste, I. Pérez González, A. Royuela Vicente, A.M. Duca, R.M. Ruiz Peralbo, C. González Hernando. ARFI elastography: Changes after direct-acting antiviral treatment in transplanted livers with relapse of hepatitis C virus infectionRadiología (English Edition) 2017; 59(2): 139 doi: 10.1016/j.rxeng.2016.12.004
16
Jennifer Berumen, Alan Hemming. Liver RetransplantationClinics in Liver Disease 2017; 21(2): 435 doi: 10.1016/j.cld.2016.12.013
17
Muhammad H. Bashir, Javid Fazili, Mohammad F. Madhoun, Rajesh Kanagala, Sixia Chen, Salman Nusrat. Impact of sustained virologic response on short-term clinical outcomes in hepatitis C-related cirrhosisEuropean Journal of Gastroenterology & Hepatology 2018; 30(3): 296 doi: 10.1097/MEG.0000000000001032
18
Julia M. Grottenthaler, Christoph R. Werner, Martina Steurer, Ulrich Spengler, Thomas Berg, Cornelius Engelmann, Heiner Wedemeyer, Thomas von Hahn, Wolfgang Stremmel, Anita Pathil, Ulrich Seybold, Eckart Schott, Usha Blessin, Christoph Sarrazin, Martin-Walter Welker, Ellen Harrer, Stefan Scholten, Clemens Hinterleitner, Ulrich M. Lauer, Nisar P. Malek, Christoph P. Berg, Chen-Hua Liu. Successful direct acting antiviral (DAA) treatment of HCV/HIV-coinfected patients before and after liver transplantationPLOS ONE 2018; 13(6): e0197544 doi: 10.1371/journal.pone.0197544
19
Janus C Jakobsen, Emil Eik Nielsen, Joshua Feinberg, Kristina Fobian, Kiran Kumar Katakam, Goran Hauser, Goran Poropat, Snezana Djurisic, Karl Heinz Weiss, Milica Bjelakovic, Goran Bjelakovic, Sarah Louise Klingenberg, Jian Ping Liu, Dimitrinka Nikolova, Ronald L Koretz, Christian Gluud, Janus C Jakobsen. Cochrane Database of Systematic Reviews2016;  doi: 10.1002/14651858.CD012143
20
Noriaki Orita, Tetsuro Shimakami, Hajime Sunagozaka, Rika Horii, Kouki Nio, Tekeshi Terashima, Noriho Iida, Masaaki Kitahara, Hajime Takatori, Kazunori Kawaguchi, Kazuya Kitamura, Kuniaki Arai, Taro Yamashita, Yoshio Sakai, Tatsuya Yamashita, Eishiro Mizukoshi, Masao Honda, Shuichi Kaneko. Three renal failure cases successfully treated with ombitasvir/paritaprevir/ritonavir for genotype 1b hepatitis C virus reinfection after liver transplantationClinical Journal of Gastroenterology 2019; 12(1): 63 doi: 10.1007/s12328-018-0884-y
21
G. Cholankeril, E. R. Yoo, M. Hu, C. Gadiparthi, M. A. Khan, R. B. Perumpail, C. A. Bonham, A. Ahmed. Rates of liver retransplantation in the United States are declining in the era of direct‐acting antiviral agentsJournal of Viral Hepatitis 2017; 24(12): 1194 doi: 10.1111/jvh.12750
22
Kylie Su Mei Yong, Zhisheng Her, Qingfeng Chen. Humanized Mouse Models for the Study of Hepatitis C and Host InteractionsCells 2019; 8(6): 604 doi: 10.3390/cells8060604
23
Shinya Maekawa, Nobuyuki Enomoto. The “real-world” efficacy and safety of DAAs for the treatment of HCV patients throughout JapanJournal of Gastroenterology 2018; 53(10): 1168 doi: 10.1007/s00535-018-1493-8
24
Ong The Due, Usa Chaikledkaew, Anne Julienne M. Genuino, Abhasnee Sobhonslidsuk, Ammarin Thakkinstian. Systematic Review with Meta-Analysis: Efficacy and Safety of Direct-Acting Antivirals for Chronic Hepatitis C Genotypes 5 and 6BioMed Research International 2019; 2019: 1 doi: 10.1155/2019/2301291